Conclusions
REMISSION
The ICd and Id regimens might be effective and well‐tolerated in elderly and frail patients with NDMM. In addition, a favorable outcome was observed that ICd might tend to cause faster and higher remission than Id regimen without increasing the risk of AEs. The long‐term effectiveness and safety of the two regimens need further investigation.ICd regimen followed by ixazomib maintenance therapy is effective, safe, convenient, and well‐tolerated in elderly and transplant‐ineligible NDMM patients.
Shutan Li and Duanzhong Zhang are the co‐author.